Alvaro Monteiro, Ph.D.H. Lee Moffitt Cancer Center & Research InstituteTampa, FL, United States Project: Tackling PARP inhibitor resistance through functional proteomics Research Areas: Chemotherapy Resistance Summary:There has been significant progress in ovarian cancer treatment especially with the development and approval of PARP inhibitor drugs. Despite this progress, a sizable percentage of patients do not respond or stop […]
Read More
Wa Xian, PhDUniversity of Texas Health Science Center at HoustonHouston, TX, United States 2019 Pilot Study Award Research in Focus: Understanding and overcoming resistance to chemotherapy Resistant Cancer Stem Cell Profile in Multi-Site Metastasis of HGSC Even though ovarian cancer is typically detected very late, advances in surgery and chemotherapy have resulted in remarkable responses in […]
Read More